Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-217

I agree with your premise but your second to last paragraph says it all. Focus with checks, that is what I’m asking for.

I also don’t want this to be sold at $4.50, but I do want a $4.50 share price and that will provide someway to minimising dilution and a defence v cheap takeover’s.

I will go on the record as the first part of the presentation that PR gave last week was the first time I’ve heard excitement in his voice in such a long time. The second part, after we’d be put to sleep by Donna, it was as if the excitement had been sucked out of him. Was it’s Donna’s monotone that did that?

Either way, we need some oomph in our presentations and some exposure through top websites such as fiercebiotech. com to move our share price.